Anti‐interleukin‐6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritisSarah Fleischer, Simon Fillatreau, Ping Shen et al.|European Journal of Immunology|2017Cited by 15